Open for submissionsPeer reviewed, fully open access, and a low article processing charge.Submit manuscript

Research ArticleOpen AccessGoogle Scholar indexed

Quantitative Structure-Activity Relationship Study of a Benzimidazole-Derived Series Inhibiting Mycobacterium tuberculosis H37Rv

,
,
,
,
  1. 1 Laboratoire de Thermodynamique et de Physico-Chimie du Milieu, UFR SFA, Université Nangui Abrogoua, Abidjan, Côte-d’Ivoire
  2. 2 Groupe Ivoirien de Recherches en Modélisation des Maladies (GIR2M), Université Nangui Abrogoua, Abidjan, Côte-d’Ivoire
Computational Chemistry·Volume 10, Issue 2·Pages 71–96·Published 11 April 2022·DOI10.4236/cc.2022.102004
Download PDF

Abstract

This work was carried out on a series of twenty-two (22) benzimidazole derivatives with inhibitory activities against Mycobacterium tuberculosis H37Rv by applying the Quantitative Structure-Activity Relationship (QSAR) method. The molecules were optimized at the level DFT/B3LYP/6-31 + G (d, p), to obtain the molecular descriptors. We used three statistical learning tools namely, the linear multiple regression (LMR) method, the nonlinear regression (NLMR) and the artificial neural network (ANN) method. These methods allowed us to obtain three (3) quantitative models from the quantum descriptors that are, chemical potential (μ), polarizability (α), bond length l (C = N), and lipophilicity. These models showed good statistical performance. Among these, the ANN has a significantly better predictive ability R2 = 0.9995; RMSE = 0.0149; F = 31879.0548. The external validation tests verify all the criteria of Tropsha et al. and Roy et al. Also, the internal validation tests show that the model has a very satisfactory internal predictive character and can be considered as robust. Moreover, the applicability range of this model determined from the levers shows that a prediction of the pMIC of the new benzimidazole derivatives is acceptable when its lever value is lower than 1.

KeywordsMycobacterium tuberculosis H37RvBenzimidazole DerivativesQSARANNApplicability Domain
  1. Institut Pasteur. https://www.pasteur.fr/fr/centre-medical/fiches-maladies/tuberculose
  2. OMS (Organisation Mondiale de la Santé) (2021) Tuberculose. https://www.who.int/fr/news-room/fact-sheets/detail/tuberculosis
  3. Gabo, G. (2021) Prévalence de la tuberculose en Côte d’Ivoire: 19 976 porteurs de la maladie dépistés en 2020. https://www.fratmat.info/article/211803/societe/santeacute/prevalence-de-la-tuberculose-en-cote-divoire-19-976-porteurs-de-la-maladie-depistes-en-2020
  4. Castagnolo, D., Manetti, F., Radi, M., Bechi, B., Pagano, M., De Logu, A., Meleddu, R., Saddi, M. and Botta, M. (2009) Synthesis, Biological Evaluation, and SAR Study of Novel Pyrazole Analogues as Inhibitors of Mycobacterium tuberculosis: Part 2. Synthesis of Rigid Pyrazolones. Bioorganic & Medicinal Chemistry, 17, 5716-5721. https://doi.org/10.1016/j.bmc.2009.05.058
  5. Raynaud, C., Daher, W., Johansen, M., Roquet-Baneres, F., Blaise, M., Onajole, O., Kozikowski, A., Herrmann, J.-L., Dziadek, J., Gobis, K. and Kremer, L. (2020) Active Benzimidazole Derivatives Targeting the MmpL3 Transporter in Mycobacterium abscessus. ACS Infectious Diseases, 6, 324-337. https://doi.org/10.1021/acsinfecdis.9b00389
  6. Garuti, L., Roberti, M., Malagoli, M., Rossi, T. and Castelli, M. (2001) Synthèse et activité antiproliférative de certains thiazolylbenzimidazole-4,7-diones. Bioorganic & Medicinal Chemistry Letters, 11, 3147-3149. https://doi.org/10.1016/S0960-894X(01)00639-4
  7. Rao, A., Chimirri, A., De Clercq, E., Monforte, A., Monforte, P., Pannecouque, C. and Zappala, M. (2002) Synthesis and Anti-HIV Activity of 1-(2,6-difluorophenyl)-1H,3H-thiazolo[3,4-a]benzimidazole Structurally-Related 1,2-substituted Benzimidazoles. Il Farmaco, 57, 819-823. https://doi.org/10.1016/S0014-827X(02)01300-9
  8. Valdez, J., Cedillo, R., Hernández-Campos, A., Yépez, L., Hernández-Luis, F., Navarrete-Vázquez, G., Tapia, A., Cortés, R., Hernández, M. and Castillo, R. (2002) Synthesis and Antiparasitic Activity of 1H-Benzimidazole Derivatives. Bioorganic & Medicinal Chemistry Letters, 12, 2221-2224. https://doi.org/10.1016/S0960-894X(02)00346-3
  9. Thakurdesai, P., Wadodkar, S. and Chopade, C. (2007) Synthesis and Anti-Inflammatory Activity of Some Benzimidazole-2-Carboxylic Acids. Pharmacologyonline, 1, 314-329.
  10. Ayhan-Kilcigil, G., Kus, C., Ozdamar, E., Can-Eke, B. and Iscan, M. (2007) Synthesis and Antioxidant Capacities of Some New Benzimidazole Derivatives. Archiv der Pharmazie, 340, 607-611. https://doi.org/10.1002/ardp.200700088
  11. Serafin, B., Borkowska, G., Główczyk, J., Kowalska, I. and Rump, S. (1989) Potential Antihypertensive Benzimidazole Derivatives. Polish Journal of Pharmacology and Pharmacy, 41, 89-96.
  12. Oprea, T.I. (2005) Chemoinformatics in Drug Discovery. Wiley-VCH Verlag GmbH & Co. KGaA, Hoboken. https://doi.org/10.1002/3527603743
  13. Rekka, E.A. and Kourounakis, P.N. (2008) Chemistry and Molecular Aspects of Drug Design and Action. CRC Press, Boca Raton. https://doi.org/10.1201/9781420008272
  14. Frisch, M.J., Trucks, G.W., Schlegel, H.B. and Scuseria, G.E. (2009) Gaussian 09, Revision A.02. Gaussian, Inc., Wallingford.
  15. Chattaraj, P.K., Cedillo, A. and Parr, R.G. (1991) Variational Method for Determining the Fukui Function and Chemical Hardness of an Electronic System. The Journal of Chemical Physics, 103, 7645-7646. https://doi.org/10.1063/1.470284
  16. Ayers, P.W. and Parr, R.G. (2000) Variational Principles for Describing Chemical Reactions: The Fukui Function and Chemical Hardness Revisited. Journal of the American Chemical Society, 122, 2010-2018. https://doi.org/10.1021/ja9924039
  17. De Proft, F.J., Martin, M.L. and Geerlings, P. (1996) On the Performance of Density Functional Methods for Describing Atomic Populations, Dipole Moments and Infrared Intensities. Chemical Physics Letters, 250, 393. https://doi.org/10.12980/APJTB.4.2014C1012
  18. Hansch, C., Sammes, P.G. and Taylor, J.B. (1990) Comprehensive Medicinal Chemistry. Computers and the Medicinal Chemist, Vol. 4, Pergamon Press, Oxford, 33-58.
  19. Franke, R. (1984) Theoretical Drug Design Methods. Elsevier, Amsterdam.
  20. Chaltterjee, S., Hadi, A. and Price, B. (2000) Regression Analysis by Examples. Wiley VCH, New York.
  21. Phuong, H. (2007) Synthèse et étude des relations structure/activité quantitatives (QSAR/2D) d’analoguesBenzo[c]phénanthridiniques. France.
  22. Microsoft Excel, Miicrosoft Office Version 2016.
  23. XLSTAT Version (2014) XLSTAT and Addinsoft are Registered Trademarks of Addinsoft.
  24. JMPPro13 (2014) Statistical Discovery. SAS Institute Inc., Scintilla, 1998-2014.
  25. Tammo (1995) Theoretical Analysis of Molecular Membrane Organization. CRC, Raton.
  26. Rutkowska, E., Pajak, K. and Jozwiak, K. (2013) Lipophilicity—Methods of Determination and Its Role in Medicinal Chemistry. Acta Poloniae Pharmaceutica: Drug Research, 70, 3-18.
  27. Bakht, M.A., Alajmi, M.F., Alam, P., Alam, A., Alam, P. and Aljarba, T.M. (2014) Theoretical and Experimental Study on Lipophilicity and Wound Healing Activity of Ginger Compounds. Asian Pacific Journal of Tropical Biomedicine, 4, 329-333. https://doi.org/10.12980/APJTB.4.2014C1012
  28. Kujawski, J., Popielarska, H., Myka, A., Drabińska, B. and Bernard, M.K. (2012) The logP Parameter as a Molecular Descriptor in the Computer-Aided Drug Design—An Overview. Computational Methods in Science and Technology, 18, 81-88. https://doi.org/10.12921/cmst.2012.18.02.81-88
  29. Cozma, A., Zaharia, V., Ignat, A., Gocan, S. and Grinberg, N. (2012) Prediction of the Lipophilicity of Nine New Synthesized Selenazoly and Three Aroyl-Hydrazinoselenazoles Derivatives by Reversed-Phase High Performance Thin-Layer Chromatography. Journal of Chromatographic Science, 50, 157-161. https://doi.org/10.1093/chromsci/bmr034
  30. Acdlabs (2010) Advanced Chemistry Development/Chemskecht, 1994-2010.
  31. Snedecor, G.W. and Cochran, W.G. (1967) Methods, Statistical. Oxford and IBH, New Delhi, 381.
  32. Kangah, N.J.-B., Koné, M.G.-R., Kodjo, C.G., N’guessan, B.R., Kablan, A.L.C., Yéo, S.A. and Ziao, N. (2017) Antibacterial Activity of Schiff Bases Derived from Ortho Diaminocyclohexane, Meta-Phenylenediamine and 1,6-Diaminohexane: Qsar Study with Quantum Descriptors. International Journal of Pharmaceutical Science Invention, 6, 38-43.
  33. Esposito, E.X., Hopfinger, A.J. and Madura, J.D. (2004) Methods for Applying the Quantitative Structure-Activity Relationship Paradigm. In: Bajorath, J., Ed., Chemoinformatics, Vol. 275, Humana Press, Totowa, 131-213. https://doi.org/10.1385/1-59259-802-1:131
  34. Eriksson, L., Jaworska, J., Worth, A., Cronin, M.D., Mc Dowell, R.M. and Gramatica, P. (2003) Methods for Reliability and Uncertainty Assessment and for Applicability Evaluations of Classification- and Regression-Based QSARs. Environmental Health Perspectives, 111, 1361-1375. https://doi.org/10.1289/ehp.5758
  35. Golbraikh, A. and Tropsha, A. (2002) Beware of q2. Journal of Molecular Graphics and Modelling, 20, 269-276. https://doi.org/10.1016/S1093-3263(01)00123-1
  36. Tropsha, A., Gramatica, P. and Gombar, V.K. (2003) The Importance of Being Earnest, Validation Is the Absolute Essential for Successful Application and Interpretation of QSPR Models. QSAR & Combinatorial Science, 22, 69-77. https://doi.org/10.1002/qsar.200390007
  37. Ouattara, O., Affi, T.S., Koné, M.G.-R., Bamba, K. and Ziao, N. (2017) Can Empirical Descriptors Reliably Predict Molecular Lipophilicity? A QSPR Study Investigation. International Journal of Engineering Research and Application, 7, 50-56. https://doi.org/10.9790/9622-0705015056
  38. Roy, P.P. and Roy, K. (2008) On Some Aspects of Variable Selection for Partial Least Squares Regression Models. QSAR & Combinatorial Science, 27, 302-313. https://doi.org/10.1002/qsar.200710043
  39. Hea, G., Fenga, L. and Chena, H. (2012) International Symposium on Safety Science and Engineering in China. Procedia Engineering, 43, 204-209.
  40. Dreyfus, G. (1998) Réseaux de neurones artificiels. Toulouse.
  41. Dreyfus, G., Martinez, J., Samuelides, M., Gordon, M., Badran, F., Thiria, S.and Herault, L. (2002) Réseaux de Neurones Artificiels. 2 édition, Groupe Eyrolles, New York, 374. https://doi.org/10.1177/026119290503300510
  42. Jeliazkova, N.N. and Jaworska, J. (2005) An Approach to Determining Applicability Domains for QSAR Group Contribution Models: An Analysis of SRC KOWWIN. Alternatives to Laboratory Animals, 33, 461-470. https://doi.org/10.1177/026119290503300510
  43. Sahigara, F., Mansouri, K., Ballabio, D., Mauri, A. and Todeschini, V.C.a.R. (2012) Comparison of Different Approaches to Define the Applicability Domain of QSAR Models. Molecules, 17, 4791-4810. https://doi.org/10.3390/molecules17054791
  44. Roy, K. (2015) Chapter 2. Statistical Methods in QSAR/QSPR. In: A Primer on QSAR/QSPR Modeling, Springer, Cham, 37-59. https://doi.org/10.1007/978-3-319-17281-1_2
  45. Jaworska, J., Jeliazkova, N.N. and Aldenberg, T. (2005) QSAR Applicability Domain Estimation by Projection of the Training Set in Descriptor Space: A Review. Alternatives to Laboratory Animals, 33, 445-459. https://doi.org/10.1155/2016/5137289
  46. Ghamali, M., Chtita, S., Bouachrine, M. and Lakhlifi, T. (2016) Méthodologie générale d’une étude RQSA/RQSP. Revue Interdisciplinaire, 1, 1-6.
  47. Chtita, S., Ghamali, M., Hmamouchi, R., Elidrissi, B., Bourass, M., Larif, M., Bouachrine, M. and Lakhlifi, T. (2016) Investigation of Antileishmanial Activities of Acridines Derivatives against Promastigotes and Amastigotes form of Parasites Using QSAR Analysis. Advances in Physical Chemistry, 2016, Article ID: 5137289. https://doi.org/10.1155/2016/5137289
  48. Asadollahi, T., Dadfarnia, S., Shabani, A., Ghasemi, J. and Sarkhosh, M. (2011) QSAR Models for CXCR2 Receptor Antagonists Based on the Genetic Algorithm for Data Preprocessing Prior to Application of the PLS Linear Regression Method and Design of the New Compounds Using in Silico Virtual Screening. Molecules, 16, 1928-1955. https://doi.org/10.3390/molecules16031928
  49. Chtita, S., Larif, M., Ghamali, M., Bouachrine, M. and Lakhlifi, T. (2015) Quantitative Structure-Activity Relationship Studies of dibenzo[a,d]cycloalkenimine Derivatives for Non-Competitive Antagonists of N-Methyl-D-Aspartate Based on Density Functional Theory with Electronic and Topological Descriptors. Journal of Taibah University for Science, 9, 143-154. https://doi.org/10.1016/j.jtusci.2014.10.006
  50. Fortuné, A. (2006) Techniques de Modélisation Moléculaire appliquées à l’Etude et à l’Optimisation de Molécules Immunogènes et de Modulateurs de la Chimiorésistance. Médicaments.
  51. Tropsha, A. (2010) Best Practices for QSAR Model Development, Validation, and Exploitation. Molecular Informatics, 29, 476-488. https://doi.org/10.1002/minf.201000061
  52. Shamsara, J. (2017) Ezqsar: An R Package for Developing QSAR Models Directly From Structures. The Open Medicinal Chemistry Journal, 11, 212-221. https://doi.org/10.1590/S0103-50532009000400021
  53. Kiralj, R., Ferreira, M.M.C. and Braz, J. (2009) Basic Validation Procedures for Regression Models in QSAR and QSPR Studies: Theory and Application. Journal of the Brazilian Chemical Society, 20, 770-787. https://doi.org/10.1590/S0103-50532009000400021
  54. Veerasamy, R., Rajak, H., Jain, A., Sivadasan, S., Varghese, C.P. and Agrawal, R.K. (2011) Validation of QSAR Models—Strategies and Importance. International Journal of Drug Design and Discovery, 2, 511-519.
  55. Gramatica, P. (2007) Principles of QSAR Models Validation: Internal and External. QSAR & Combinatorial Science, 26, 694-701. https://doi.org/10.1002/qsar.200610151